10-79559458-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001098668.4(SFTPA2):​c.26C>A​(p.Thr9Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.601 in 1,350,312 control chromosomes in the GnomAD database, including 280,757 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 21170 hom., cov: 27)
Exomes 𝑓: 0.61 ( 259587 hom. )

Consequence

SFTPA2
NM_001098668.4 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.14

Publications

47 publications found
Variant links:
Genes affected
SFTPA2 (HGNC:10799): (surfactant protein A2) This gene is one of several genes encoding pulmonary-surfactant associated proteins (SFTPA) located on chromosome 10. Mutations in this gene and a highly similar gene located nearby, which affect the highly conserved carbohydrate recognition domain, are associated with idiopathic pulmonary fibrosis. The current version of the assembly displays only a single centromeric SFTPA gene pair rather than the two gene pairs shown in the previous assembly which were thought to have resulted from a duplication. [provided by RefSeq, Sep 2009]
SFTPA2 Gene-Disease associations (from GenCC):
  • interstitial lung disease 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • idiopathic pulmonary fibrosis
    Inheritance: Unknown, AD Classification: MODERATE, LIMITED Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.684461E-4).
BP6
Variant 10-79559458-G-T is Benign according to our data. Variant chr10-79559458-G-T is described in ClinVar as Benign. ClinVar VariationId is 227066.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.601 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SFTPA2NM_001098668.4 linkc.26C>A p.Thr9Asn missense_variant Exon 3 of 6 ENST00000372325.7 NP_001092138.1 Q8IWL1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SFTPA2ENST00000372325.7 linkc.26C>A p.Thr9Asn missense_variant Exon 3 of 6 1 NM_001098668.4 ENSP00000361400.2 Q8IWL1

Frequencies

GnomAD3 genomes
AF:
0.523
AC:
77988
AN:
149154
Hom.:
21171
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.390
Gnomad AMI
AF:
0.756
Gnomad AMR
AF:
0.504
Gnomad ASJ
AF:
0.430
Gnomad EAS
AF:
0.533
Gnomad SAS
AF:
0.446
Gnomad FIN
AF:
0.583
Gnomad MID
AF:
0.404
Gnomad NFE
AF:
0.606
Gnomad OTH
AF:
0.494
GnomAD2 exomes
AF:
0.455
AC:
84524
AN:
185672
AF XY:
0.451
show subpopulations
Gnomad AFR exome
AF:
0.259
Gnomad AMR exome
AF:
0.430
Gnomad ASJ exome
AF:
0.334
Gnomad EAS exome
AF:
0.431
Gnomad FIN exome
AF:
0.529
Gnomad NFE exome
AF:
0.512
Gnomad OTH exome
AF:
0.483
GnomAD4 exome
AF:
0.611
AC:
733932
AN:
1201044
Hom.:
259587
Cov.:
79
AF XY:
0.604
AC XY:
363151
AN XY:
600936
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.349
AC:
9836
AN:
28202
American (AMR)
AF:
0.501
AC:
19901
AN:
39718
Ashkenazi Jewish (ASJ)
AF:
0.422
AC:
9786
AN:
23208
East Asian (EAS)
AF:
0.535
AC:
19542
AN:
36550
South Asian (SAS)
AF:
0.443
AC:
34136
AN:
77118
European-Finnish (FIN)
AF:
0.574
AC:
29271
AN:
50954
Middle Eastern (MID)
AF:
0.356
AC:
1815
AN:
5102
European-Non Finnish (NFE)
AF:
0.653
AC:
580273
AN:
888690
Other (OTH)
AF:
0.570
AC:
29372
AN:
51502
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.328
Heterozygous variant carriers
0
16689
33378
50067
66756
83445
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12930
25860
38790
51720
64650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.523
AC:
77999
AN:
149268
Hom.:
21170
Cov.:
27
AF XY:
0.516
AC XY:
37536
AN XY:
72740
show subpopulations
African (AFR)
AF:
0.390
AC:
15796
AN:
40540
American (AMR)
AF:
0.504
AC:
7593
AN:
15062
Ashkenazi Jewish (ASJ)
AF:
0.430
AC:
1478
AN:
3440
East Asian (EAS)
AF:
0.533
AC:
2655
AN:
4982
South Asian (SAS)
AF:
0.445
AC:
2097
AN:
4714
European-Finnish (FIN)
AF:
0.583
AC:
6010
AN:
10308
Middle Eastern (MID)
AF:
0.414
AC:
121
AN:
292
European-Non Finnish (NFE)
AF:
0.606
AC:
40565
AN:
66978
Other (OTH)
AF:
0.490
AC:
1011
AN:
2062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.420
Heterozygous variant carriers
0
1728
3455
5183
6910
8638
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
682
1364
2046
2728
3410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.520
Hom.:
7347
Bravo
AF:
0.517
ExAC
AF:
0.358
AC:
43356

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24950659) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 12, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Thr9Asn in exon 3 of SFTPA2: This variant is not expected to have clinical sig nificance it has been identified in 41% (22324/54314) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP r s1059046). -

SFTPA2-related disorder Benign:1
Apr 26, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.85
T
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.21
DANN
Benign
0.71
Eigen
Benign
-0.87
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.018
N
LIST_S2
Benign
0.29
.;.;T;T;T
MetaRNN
Benign
0.00037
T;T;T;T;T
MetaSVM
Benign
-0.93
T
PhyloP100
-1.1
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.0
N;N;N;.;.
REVEL
Benign
0.042
Sift
Benign
0.24
T;T;T;.;.
Sift4G
Benign
0.17
T;T;T;.;.
Vest4
0.13
MPC
1.6
ClinPred
0.018
T
GERP RS
0.64
PromoterAI
-0.014
Neutral
gMVP
0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1059046; hg19: chr10-81319214; COSMIC: COSV64882118; API